Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iteos Therapeutics Inc (ITOS)

Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 448,681
  • Shares Outstanding, K 44,205
  • Annual Sales, $ 35,000 K
  • Annual Income, $ -134,410 K
  • EBIT $ -222 M
  • EBITDA $ -232 M
  • 60-Month Beta 1.49
  • Price/Sales 12.79
  • Price/Cash Flow N/A
  • Price/Book 0.79
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.37
  • Most Recent Earnings $-1.51 on 08/06/25
  • Next Earnings Date 11/11/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.08 +0.69%
on 08/05/25
10.22 -0.68%
on 08/22/25
+0.04 (+0.40%)
since 07/28/25
3-Month
9.85 +3.05%
on 05/30/25
10.47 -3.06%
on 07/21/25
+0.09 (+0.89%)
since 05/28/25
52-Week
4.80 +111.46%
on 04/09/25
17.63 -42.43%
on 09/12/24
-7.00 (-40.82%)
since 08/28/24

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and KLG on Behalf of Shareholders

NEW YORK , Aug. 20, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KLG : 23.00 (unch)
ITOS : 10.15 (+0.20%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA, CORZ, ITOS, VBTX on Behalf of Shareholders

NEW YORK , Aug. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

STAA : 23.21 (-0.73%)
VBTX : 30.26 (+1.00%)
CORZ : 14.61 (-3.12%)
ITOS : 10.15 (+0.20%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, VBTX, ITOS, WNS on Behalf of Shareholders

NEW YORK , July 30, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

OLO : 10.26 (unch)
VBTX : 30.26 (+1.00%)
ITOS : 10.15 (+0.20%)
WNS : 76.48 (+0.10%)
ITEOS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iTeos Therapeutics, Inc. - ITOS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of iTeos Therapeutics, Inc. (NasdaqGM:...

ITOS : 10.15 (+0.20%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of iTeos Therapeutics, Inc.

NEW YORK , July 21, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by iTeos Therapeutics, Inc. (NASDAQ: ITOS) and its board of directors concerning...

ITOS : 10.15 (+0.20%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, ZIMV, XAGE on Behalf of Shareholders

NEW YORK , July 21, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ZIMV : 18.99 (unch)
ITOS : 10.15 (+0.20%)
XAGE : 0.3500 (-0.03%)
ITOS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iTeos Therapeutics, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of iTeos Therapeutics, Inc. (NASDAQ: ITOS) to Concentra Biosciences, LLC is fair to iTeos shareholders. Under the terms...

ITOS : 10.15 (+0.20%)
iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right

WATERTOWN, Mass. and GOSSELIES, Belgium, July 21, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (“iTeos”) (Nasdaq: ITOS) today announced that it has entered into a definitive merger agreement...

ITOS : 10.15 (+0.20%)
iTeos Therapeutics Announces Its Intention to Wind Down Operations

ITOS : 10.15 (+0.20%)
iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients

ITOS : 10.15 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar